RAM
COGT icon

Readystate Asset Management’s Cogent Biosciences COGT Stock Holding History

Readystate Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,692
Closed -$714K – 408
2025
Q3 		$714K Buy
+49,692
New +$589K 0.03% 217
2025
Q2 		– Sell
-350,180
Closed -$2.1M – 675
2025
Q1 		$2.1M Sell
350,180
-169,820
-33% -$1.33M 0.07% 320
2024
Q4 		$4.06M Buy
+520,000
New +$5.18M 0.12% 170
2024
Q3 		– Sell
-734,197
Closed -$6.19M – 593
2024
Q2 		$6.19M Buy
734,197
+196,997
+37% +$1.49M 0.2% 91
2024
Q1 		$3.61M Buy
+537,200
New +$3.32M 0.05% 429

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Readystate Asset Management's COGT Position: Q4 2025 in Review

Readystate Asset Management sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 49,692 shares — an estimated $714K sold.

Readystate Asset Management first reported a position in COGT in Q1 2024 and held it in 5 quarters. The position peaked at $6.19M in Q2 2024. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Readystate Asset Management reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Readystate Asset Management sold 49,692 Cogent Biosciences shares in Q4 2025, an estimated $714K.
  • Readystate Asset Management first reported a position in Cogent Biosciences in Q1 2024 and held it in 5 quarters.
  • Readystate Asset Management's Cogent Biosciences position peaked at $6.19M in Q2 2024.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.